This guideline updates and widens the scope of the previ-ous British Society for Haematology (BSH) Clinical guide-lines for Diagnosis and Management of Heparin-Induced Thrombocytopenia: Second Edition1 to include functional assays in the diagnosis of heparin-induced thrombocy...
This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use ...
COVID-19/traitement médicamenteux,
Hormones corticosurrénaliennes/usage thérapeutique,
Antiviraux/usage thérapeutique,
COVID-19/complications,
Embolie pulmonaire/complications,
Poumon/anatomopathologie,
Anticoagulants/usage thérapeutique,
Dabigatran/usage thérapeutique,
Héparine/usage thérapeutique,
4-Hydroxycoumarines/usage thérapeutique,
Acide acétylsalicylique/usage thérapeutique
The primary objective of this clinical practice guideline is to provide gynaecologists with an algorithm and evidence to guide the use of thromboprophylaxis in gynaecological surgery. All patients undergoing gynaecological surgery for benign or malignant indications. The implementation of this guideline ...
Falavigna, Maicon;
Colpani, Verônica;
Stein, Cinara;
Azevedo, Luciano César Pontes;
Bagattini, Ângela Maria;
Brito, Gabriela Vilela de;
Chatkin, José Miguel;
Cimerman, Sérgio;
Corradi, Mirian de Freitas Dal Ben;
Cunha, Clóvis Arns da;
Medeiros, Flávia Cordeiro de;
Oliveira Júnior, Haliton Alves de;
Fritscher , Leandro Genehr;
Gazzana, Marcelo Basso;
Graf, Débora Dalmas;
Marra, Lays Pires;
Matuoka , Jéssica Yumi;
Nunes, Michelle Silva;
Pachito, Daniela Vianna;
Pagano, Cássia Garcia Moraes;
Parreira, Patrícia do Carmo Silva;
Riera, Rachel;
Silva Júnior, Amilton;
Tavares, Bruno de Melo;
Zavascki, Alexandre Prehn;
Rosa, Régis Goulart;
Dal-Pizzol, Felipe.
Different therapies are currently used, considered, or proposed for the treatment of COVID-19; for many of those therapies, no appropriate assessment of effectiveness and safety was performed. This document aims to provide scientifically available evidence-based information in a transparent interpretatio...
Infections à coronavirus/traitement médicamenteux,
Aminoquinoléines/usage thérapeutique,
Oséltamivir/usage thérapeutique,
Lopinavir/usage thérapeutique,
Ritonavir/usage thérapeutique,
Hormones corticosurrénaliennes/usage thérapeutique,
Héparine/usage thérapeutique,
Antibactériens/usage thérapeutique,
Betacoronavirus/effets des médicaments et des substances chimiques,
Pneumopathie virale/traitement médicamenteux,
Pandémies/prévention et contrôle
La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible a disposición del personal del primer, segundo o tercer nivel de atención con la intención de estandarizar las acciones n...
